UPLOAD Filing
Cellectar Biosciences, Inc.
Date: May 29, 2025 · CIK: 0001279704 · Accession: 0000000000-25-005673
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Cellectar Biosciences, Inc. Draft Registration Statement on Form S-1 Submitted May 23, 2025 CIK No. 0001279704 Dear James Caruso:
May 29, 2025
James Caruso Chief Executive Officer Cellectar Biosciences, Inc. 100 Campus Drive Florham Park, NJ 07932
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Istvan Hajdu
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 29, 2025 James Caruso Chief Executive Officer Cellectar Biosciences, Inc. 100 Campus Drive Florham Park, NJ 07932 Re: Cellectar Biosciences, Inc. Draft Registration Statement on Form S-1 Submitted May 23, 2025 CIK No. 0001279704 Dear James Caruso: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Istvan Hajdu </TEXT> </DOCUMENT>